nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP1A2—Pentoxifylline—systemic scleroderma	0.16	0.251	CbGbCtD
Rimonabant—CYP1A2—Leflunomide—systemic scleroderma	0.153	0.239	CbGbCtD
Rimonabant—CYP2C9—Leflunomide—systemic scleroderma	0.138	0.216	CbGbCtD
Rimonabant—CYP2D6—Captopril—systemic scleroderma	0.099	0.155	CbGbCtD
Rimonabant—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0496	0.0775	CbGbCtD
Rimonabant—CYP3A4—Prednisone—systemic scleroderma	0.0396	0.0619	CbGbCtD
Rimonabant—CYP2C9—cardial valve—systemic scleroderma	0.00258	0.725	CbGeAlD
Rimonabant—Mental disorder—Leflunomide—systemic scleroderma	0.00119	0.00334	CcSEcCtD
Rimonabant—Malnutrition—Leflunomide—systemic scleroderma	0.00118	0.00332	CcSEcCtD
Rimonabant—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00118	0.0033	CcSEcCtD
Rimonabant—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00117	0.00327	CcSEcCtD
Rimonabant—Hallucination—Lisinopril—systemic scleroderma	0.00116	0.00326	CcSEcCtD
Rimonabant—Decreased appetite—Mometasone—systemic scleroderma	0.00116	0.00325	CcSEcCtD
Rimonabant—Fatigue—Mometasone—systemic scleroderma	0.00115	0.00322	CcSEcCtD
Rimonabant—Infestation—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00319	CcSEcCtD
Rimonabant—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00319	CcSEcCtD
Rimonabant—Muscle spasms—Leflunomide—systemic scleroderma	0.00114	0.00319	CcSEcCtD
Rimonabant—Depression—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00319	CcSEcCtD
Rimonabant—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00114	0.00318	CcSEcCtD
Rimonabant—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00113	0.00316	CcSEcCtD
Rimonabant—Anorexia—Captopril—systemic scleroderma	0.00112	0.00313	CcSEcCtD
Rimonabant—Asthenia—Pentoxifylline—systemic scleroderma	0.00111	0.00311	CcSEcCtD
Rimonabant—Tension—Mycophenolic acid—systemic scleroderma	0.00111	0.0031	CcSEcCtD
Rimonabant—Nervousness—Mycophenolic acid—systemic scleroderma	0.0011	0.00307	CcSEcCtD
Rimonabant—Pruritus—Pentoxifylline—systemic scleroderma	0.00109	0.00307	CcSEcCtD
Rimonabant—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00109	0.00306	CcSEcCtD
Rimonabant—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00108	0.00304	CcSEcCtD
Rimonabant—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.00107	0.003	CcSEcCtD
Rimonabant—Amnesia—Prednisone—systemic scleroderma	0.00107	0.00299	CcSEcCtD
Rimonabant—Insomnia—Captopril—systemic scleroderma	0.00106	0.00297	CcSEcCtD
Rimonabant—Angiopathy—Lisinopril—systemic scleroderma	0.00106	0.00297	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00106	0.00297	CcSEcCtD
Rimonabant—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00106	0.00296	CcSEcCtD
Rimonabant—Tremor—Mycophenolic acid—systemic scleroderma	0.00106	0.00296	CcSEcCtD
Rimonabant—Abdominal pain—Mometasone—systemic scleroderma	0.00105	0.00296	CcSEcCtD
Rimonabant—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00105	0.00295	CcSEcCtD
Rimonabant—Paraesthesia—Captopril—systemic scleroderma	0.00105	0.00295	CcSEcCtD
Rimonabant—Mental disorder—Lisinopril—systemic scleroderma	0.00102	0.00287	CcSEcCtD
Rimonabant—Lethargy—Prednisone—systemic scleroderma	0.00102	0.00287	CcSEcCtD
Rimonabant—Dizziness—Pentoxifylline—systemic scleroderma	0.00102	0.00286	CcSEcCtD
Rimonabant—Decreased appetite—Captopril—systemic scleroderma	0.00102	0.00285	CcSEcCtD
Rimonabant—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00285	CcSEcCtD
Rimonabant—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00285	CcSEcCtD
Rimonabant—Malnutrition—Lisinopril—systemic scleroderma	0.00102	0.00285	CcSEcCtD
Rimonabant—Infection—Azathioprine—systemic scleroderma	0.00102	0.00285	CcSEcCtD
Rimonabant—Fatigue—Captopril—systemic scleroderma	0.00101	0.00283	CcSEcCtD
Rimonabant—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00282	CcSEcCtD
Rimonabant—Anxiety—Leflunomide—systemic scleroderma	0.001	0.00281	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.001	0.0028	CcSEcCtD
Rimonabant—Tension—Lisinopril—systemic scleroderma	0.000997	0.0028	CcSEcCtD
Rimonabant—Skin disorder—Azathioprine—systemic scleroderma	0.000993	0.00278	CcSEcCtD
Rimonabant—Nervousness—Lisinopril—systemic scleroderma	0.000987	0.00277	CcSEcCtD
Rimonabant—Dry mouth—Leflunomide—systemic scleroderma	0.000985	0.00276	CcSEcCtD
Rimonabant—Vomiting—Pentoxifylline—systemic scleroderma	0.000983	0.00275	CcSEcCtD
Rimonabant—Psychotic disorder—Prednisone—systemic scleroderma	0.000979	0.00274	CcSEcCtD
Rimonabant—Convulsion—Mycophenolic acid—systemic scleroderma	0.000978	0.00274	CcSEcCtD
Rimonabant—Muscle spasms—Lisinopril—systemic scleroderma	0.000977	0.00274	CcSEcCtD
Rimonabant—Rash—Pentoxifylline—systemic scleroderma	0.000974	0.00273	CcSEcCtD
Rimonabant—Dermatitis—Pentoxifylline—systemic scleroderma	0.000974	0.00273	CcSEcCtD
Rimonabant—Headache—Pentoxifylline—systemic scleroderma	0.000968	0.00271	CcSEcCtD
Rimonabant—Infection—Leflunomide—systemic scleroderma	0.000959	0.00269	CcSEcCtD
Rimonabant—Gastrointestinal pain—Captopril—systemic scleroderma	0.000958	0.00268	CcSEcCtD
Rimonabant—Anxiety—Mycophenolic acid—systemic scleroderma	0.000957	0.00268	CcSEcCtD
Rimonabant—Asthenia—Mometasone—systemic scleroderma	0.000957	0.00268	CcSEcCtD
Rimonabant—Irritability—Prednisone—systemic scleroderma	0.000957	0.00268	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000954	0.00267	CcSEcCtD
Rimonabant—Tremor—Lisinopril—systemic scleroderma	0.000952	0.00267	CcSEcCtD
Rimonabant—Mood swings—Prednisone—systemic scleroderma	0.00095	0.00266	CcSEcCtD
Rimonabant—Nervous system disorder—Leflunomide—systemic scleroderma	0.000947	0.00265	CcSEcCtD
Rimonabant—Pruritus—Mometasone—systemic scleroderma	0.000944	0.00264	CcSEcCtD
Rimonabant—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00094	0.00263	CcSEcCtD
Rimonabant—Skin disorder—Leflunomide—systemic scleroderma	0.000938	0.00263	CcSEcCtD
Rimonabant—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000933	0.00262	CcSEcCtD
Rimonabant—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000928	0.0026	CcSEcCtD
Rimonabant—Abdominal pain—Captopril—systemic scleroderma	0.000926	0.0026	CcSEcCtD
Rimonabant—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000922	0.00258	CcSEcCtD
Rimonabant—Anorexia—Leflunomide—systemic scleroderma	0.00092	0.00258	CcSEcCtD
Rimonabant—Nausea—Pentoxifylline—systemic scleroderma	0.000918	0.00257	CcSEcCtD
Rimonabant—Infection—Mycophenolic acid—systemic scleroderma	0.000915	0.00256	CcSEcCtD
Rimonabant—Diarrhoea—Mometasone—systemic scleroderma	0.000912	0.00256	CcSEcCtD
Rimonabant—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000903	0.00253	CcSEcCtD
Rimonabant—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000896	0.00251	CcSEcCtD
Rimonabant—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000895	0.00251	CcSEcCtD
Rimonabant—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000891	0.0025	CcSEcCtD
Rimonabant—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00089	0.0025	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000883	0.00247	CcSEcCtD
Rimonabant—Anorexia—Mycophenolic acid—systemic scleroderma	0.000878	0.00246	CcSEcCtD
Rimonabant—Tension—Mycophenolate mofetil—systemic scleroderma	0.000874	0.00245	CcSEcCtD
Rimonabant—Insomnia—Leflunomide—systemic scleroderma	0.000873	0.00245	CcSEcCtD
Rimonabant—Paraesthesia—Leflunomide—systemic scleroderma	0.000867	0.00243	CcSEcCtD
Rimonabant—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000865	0.00242	CcSEcCtD
Rimonabant—Anxiety—Lisinopril—systemic scleroderma	0.000862	0.00242	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000859	0.00241	CcSEcCtD
Rimonabant—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000856	0.0024	CcSEcCtD
Rimonabant—Lethargy—Methotrexate—systemic scleroderma	0.000855	0.0024	CcSEcCtD
Rimonabant—Vomiting—Mometasone—systemic scleroderma	0.000848	0.00238	CcSEcCtD
Rimonabant—Dry mouth—Lisinopril—systemic scleroderma	0.000846	0.00237	CcSEcCtD
Rimonabant—Rash—Mometasone—systemic scleroderma	0.000841	0.00236	CcSEcCtD
Rimonabant—Asthenia—Captopril—systemic scleroderma	0.00084	0.00236	CcSEcCtD
Rimonabant—Dermatitis—Mometasone—systemic scleroderma	0.00084	0.00235	CcSEcCtD
Rimonabant—Decreased appetite—Leflunomide—systemic scleroderma	0.000839	0.00235	CcSEcCtD
Rimonabant—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000836	0.00234	CcSEcCtD
Rimonabant—Headache—Mometasone—systemic scleroderma	0.000835	0.00234	CcSEcCtD
Rimonabant—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000834	0.00234	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000833	0.00234	CcSEcCtD
Rimonabant—Insomnia—Mycophenolic acid—systemic scleroderma	0.000833	0.00233	CcSEcCtD
Rimonabant—Fatigue—Leflunomide—systemic scleroderma	0.000832	0.00233	CcSEcCtD
Rimonabant—Pruritus—Captopril—systemic scleroderma	0.000829	0.00232	CcSEcCtD
Rimonabant—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000827	0.00232	CcSEcCtD
Rimonabant—Infection—Lisinopril—systemic scleroderma	0.000824	0.00231	CcSEcCtD
Rimonabant—Abdominal pain—Azathioprine—systemic scleroderma	0.000808	0.00227	CcSEcCtD
Rimonabant—Skin disorder—Lisinopril—systemic scleroderma	0.000806	0.00226	CcSEcCtD
Rimonabant—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000802	0.00225	CcSEcCtD
Rimonabant—Diarrhoea—Captopril—systemic scleroderma	0.000801	0.00225	CcSEcCtD
Rimonabant—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000801	0.00224	CcSEcCtD
Rimonabant—Irritability—Methotrexate—systemic scleroderma	0.0008	0.00224	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000795	0.00223	CcSEcCtD
Rimonabant—Fatigue—Mycophenolic acid—systemic scleroderma	0.000794	0.00223	CcSEcCtD
Rimonabant—Mood swings—Methotrexate—systemic scleroderma	0.000794	0.00222	CcSEcCtD
Rimonabant—Nausea—Mometasone—systemic scleroderma	0.000792	0.00222	CcSEcCtD
Rimonabant—Anorexia—Lisinopril—systemic scleroderma	0.000791	0.00222	CcSEcCtD
Rimonabant—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000789	0.00221	CcSEcCtD
Rimonabant—Dizziness—Captopril—systemic scleroderma	0.000775	0.00217	CcSEcCtD
Rimonabant—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000772	0.00216	CcSEcCtD
Rimonabant—Depression—Prednisone—systemic scleroderma	0.00077	0.00216	CcSEcCtD
Rimonabant—Abdominal pain—Leflunomide—systemic scleroderma	0.000763	0.00214	CcSEcCtD
Rimonabant—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000756	0.00212	CcSEcCtD
Rimonabant—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000753	0.00211	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000753	0.00211	CcSEcCtD
Rimonabant—Insomnia—Lisinopril—systemic scleroderma	0.00075	0.0021	CcSEcCtD
Rimonabant—Paraesthesia—Lisinopril—systemic scleroderma	0.000745	0.00209	CcSEcCtD
Rimonabant—Vomiting—Captopril—systemic scleroderma	0.000745	0.00209	CcSEcCtD
Rimonabant—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000741	0.00208	CcSEcCtD
Rimonabant—Rash—Captopril—systemic scleroderma	0.000739	0.00207	CcSEcCtD
Rimonabant—Dermatitis—Captopril—systemic scleroderma	0.000738	0.00207	CcSEcCtD
Rimonabant—Headache—Captopril—systemic scleroderma	0.000734	0.00206	CcSEcCtD
Rimonabant—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000728	0.00204	CcSEcCtD
Rimonabant—Infection—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00202	CcSEcCtD
Rimonabant—Decreased appetite—Lisinopril—systemic scleroderma	0.000721	0.00202	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000716	0.00201	CcSEcCtD
Rimonabant—Fatigue—Lisinopril—systemic scleroderma	0.000715	0.002	CcSEcCtD
Rimonabant—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000713	0.002	CcSEcCtD
Rimonabant—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000706	0.00198	CcSEcCtD
Rimonabant—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000703	0.00197	CcSEcCtD
Rimonabant—Diarrhoea—Azathioprine—systemic scleroderma	0.000699	0.00196	CcSEcCtD
Rimonabant—Nausea—Captopril—systemic scleroderma	0.000696	0.00195	CcSEcCtD
Rimonabant—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000694	0.00195	CcSEcCtD
Rimonabant—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000693	0.00194	CcSEcCtD
Rimonabant—Asthenia—Leflunomide—systemic scleroderma	0.000693	0.00194	CcSEcCtD
Rimonabant—Hallucination—Prednisone—systemic scleroderma	0.00069	0.00193	CcSEcCtD
Rimonabant—Pruritus—Leflunomide—systemic scleroderma	0.000683	0.00191	CcSEcCtD
Rimonabant—Connective tissue disorder—Prednisone—systemic scleroderma	0.000681	0.00191	CcSEcCtD
Rimonabant—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000678	0.0019	CcSEcCtD
Rimonabant—Dizziness—Azathioprine—systemic scleroderma	0.000676	0.00189	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000673	0.00189	CcSEcCtD
Rimonabant—Asthenia—Mycophenolic acid—systemic scleroderma	0.000661	0.00185	CcSEcCtD
Rimonabant—Diarrhoea—Leflunomide—systemic scleroderma	0.000661	0.00185	CcSEcCtD
Rimonabant—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000657	0.00184	CcSEcCtD
Rimonabant—Abdominal pain—Lisinopril—systemic scleroderma	0.000656	0.00184	CcSEcCtD
Rimonabant—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000653	0.00183	CcSEcCtD
Rimonabant—Pruritus—Mycophenolic acid—systemic scleroderma	0.000652	0.00183	CcSEcCtD
Rimonabant—Vomiting—Azathioprine—systemic scleroderma	0.00065	0.00182	CcSEcCtD
Rimonabant—Infestation—Methotrexate—systemic scleroderma	0.000646	0.00181	CcSEcCtD
Rimonabant—Infestation NOS—Methotrexate—systemic scleroderma	0.000646	0.00181	CcSEcCtD
Rimonabant—Rash—Azathioprine—systemic scleroderma	0.000645	0.00181	CcSEcCtD
Rimonabant—Dermatitis—Azathioprine—systemic scleroderma	0.000644	0.00181	CcSEcCtD
Rimonabant—Depression—Methotrexate—systemic scleroderma	0.000644	0.0018	CcSEcCtD
Rimonabant—Headache—Azathioprine—systemic scleroderma	0.00064	0.0018	CcSEcCtD
Rimonabant—Dizziness—Leflunomide—systemic scleroderma	0.000638	0.00179	CcSEcCtD
Rimonabant—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000632	0.00177	CcSEcCtD
Rimonabant—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00063	0.00177	CcSEcCtD
Rimonabant—Angiopathy—Prednisone—systemic scleroderma	0.000629	0.00176	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000627	0.00176	CcSEcCtD
Rimonabant—Vomiting—Leflunomide—systemic scleroderma	0.000614	0.00172	CcSEcCtD
Rimonabant—Dizziness—Mycophenolic acid—systemic scleroderma	0.000609	0.00171	CcSEcCtD
Rimonabant—Rash—Leflunomide—systemic scleroderma	0.000609	0.00171	CcSEcCtD
Rimonabant—Dermatitis—Leflunomide—systemic scleroderma	0.000608	0.0017	CcSEcCtD
Rimonabant—Mental disorder—Prednisone—systemic scleroderma	0.000608	0.0017	CcSEcCtD
Rimonabant—Nausea—Azathioprine—systemic scleroderma	0.000607	0.0017	CcSEcCtD
Rimonabant—Headache—Leflunomide—systemic scleroderma	0.000605	0.0017	CcSEcCtD
Rimonabant—Malnutrition—Prednisone—systemic scleroderma	0.000604	0.00169	CcSEcCtD
Rimonabant—Asthenia—Lisinopril—systemic scleroderma	0.000595	0.00167	CcSEcCtD
Rimonabant—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000594	0.00167	CcSEcCtD
Rimonabant—Pruritus—Lisinopril—systemic scleroderma	0.000587	0.00165	CcSEcCtD
Rimonabant—Vomiting—Mycophenolic acid—systemic scleroderma	0.000586	0.00164	CcSEcCtD
Rimonabant—Rash—Mycophenolic acid—systemic scleroderma	0.000581	0.00163	CcSEcCtD
Rimonabant—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00058	0.00163	CcSEcCtD
Rimonabant—Headache—Mycophenolic acid—systemic scleroderma	0.000577	0.00162	CcSEcCtD
Rimonabant—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000575	0.00161	CcSEcCtD
Rimonabant—Nausea—Leflunomide—systemic scleroderma	0.000573	0.00161	CcSEcCtD
Rimonabant—Diarrhoea—Lisinopril—systemic scleroderma	0.000568	0.00159	CcSEcCtD
Rimonabant—Dizziness—Lisinopril—systemic scleroderma	0.000549	0.00154	CcSEcCtD
Rimonabant—Nausea—Mycophenolic acid—systemic scleroderma	0.000547	0.00153	CcSEcCtD
Rimonabant—Vomiting—Lisinopril—systemic scleroderma	0.000527	0.00148	CcSEcCtD
Rimonabant—Angiopathy—Methotrexate—systemic scleroderma	0.000526	0.00147	CcSEcCtD
Rimonabant—Rash—Lisinopril—systemic scleroderma	0.000523	0.00147	CcSEcCtD
Rimonabant—Convulsion—Prednisone—systemic scleroderma	0.000523	0.00147	CcSEcCtD
Rimonabant—Dermatitis—Lisinopril—systemic scleroderma	0.000523	0.00146	CcSEcCtD
Rimonabant—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000522	0.00146	CcSEcCtD
Rimonabant—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000521	0.00146	CcSEcCtD
Rimonabant—Headache—Lisinopril—systemic scleroderma	0.00052	0.00146	CcSEcCtD
Rimonabant—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000514	0.00144	CcSEcCtD
Rimonabant—Anxiety—Prednisone—systemic scleroderma	0.000512	0.00144	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00051	0.00143	CcSEcCtD
Rimonabant—Mental disorder—Methotrexate—systemic scleroderma	0.000508	0.00142	CcSEcCtD
Rimonabant—Malnutrition—Methotrexate—systemic scleroderma	0.000504	0.00141	CcSEcCtD
Rimonabant—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000497	0.00139	CcSEcCtD
Rimonabant—Nausea—Lisinopril—systemic scleroderma	0.000493	0.00138	CcSEcCtD
Rimonabant—Infection—Prednisone—systemic scleroderma	0.000489	0.00137	CcSEcCtD
Rimonabant—Nervous system disorder—Prednisone—systemic scleroderma	0.000483	0.00135	CcSEcCtD
Rimonabant—CNR1—lung—systemic scleroderma	0.000482	0.135	CbGeAlD
Rimonabant—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000481	0.00135	CcSEcCtD
Rimonabant—Skin disorder—Prednisone—systemic scleroderma	0.000479	0.00134	CcSEcCtD
Rimonabant—Hyperhidrosis—Prednisone—systemic scleroderma	0.000476	0.00133	CcSEcCtD
Rimonabant—Anorexia—Prednisone—systemic scleroderma	0.00047	0.00132	CcSEcCtD
Rimonabant—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000462	0.0013	CcSEcCtD
Rimonabant—Rash—Mycophenolate mofetil—systemic scleroderma	0.000458	0.00128	CcSEcCtD
Rimonabant—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000458	0.00128	CcSEcCtD
Rimonabant—Headache—Mycophenolate mofetil—systemic scleroderma	0.000455	0.00128	CcSEcCtD
Rimonabant—Insomnia—Prednisone—systemic scleroderma	0.000446	0.00125	CcSEcCtD
Rimonabant—Paraesthesia—Prednisone—systemic scleroderma	0.000442	0.00124	CcSEcCtD
Rimonabant—Convulsion—Methotrexate—systemic scleroderma	0.000437	0.00123	CcSEcCtD
Rimonabant—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000432	0.00121	CcSEcCtD
Rimonabant—Decreased appetite—Prednisone—systemic scleroderma	0.000428	0.0012	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000427	0.0012	CcSEcCtD
Rimonabant—Fatigue—Prednisone—systemic scleroderma	0.000425	0.00119	CcSEcCtD
Rimonabant—Infection—Methotrexate—systemic scleroderma	0.000409	0.00115	CcSEcCtD
Rimonabant—Nervous system disorder—Methotrexate—systemic scleroderma	0.000404	0.00113	CcSEcCtD
Rimonabant—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000403	0.00113	CcSEcCtD
Rimonabant—Skin disorder—Methotrexate—systemic scleroderma	0.0004	0.00112	CcSEcCtD
Rimonabant—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000398	0.00112	CcSEcCtD
Rimonabant—Anorexia—Methotrexate—systemic scleroderma	0.000392	0.0011	CcSEcCtD
Rimonabant—Abdominal pain—Prednisone—systemic scleroderma	0.000389	0.00109	CcSEcCtD
Rimonabant—Insomnia—Methotrexate—systemic scleroderma	0.000372	0.00104	CcSEcCtD
Rimonabant—Paraesthesia—Methotrexate—systemic scleroderma	0.00037	0.00104	CcSEcCtD
Rimonabant—Decreased appetite—Methotrexate—systemic scleroderma	0.000358	0.001	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000355	0.000996	CcSEcCtD
Rimonabant—Fatigue—Methotrexate—systemic scleroderma	0.000355	0.000995	CcSEcCtD
Rimonabant—Asthenia—Prednisone—systemic scleroderma	0.000353	0.000991	CcSEcCtD
Rimonabant—Pruritus—Prednisone—systemic scleroderma	0.000349	0.000977	CcSEcCtD
Rimonabant—Diarrhoea—Prednisone—systemic scleroderma	0.000337	0.000945	CcSEcCtD
Rimonabant—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000337	0.000944	CcSEcCtD
Rimonabant—Dizziness—Prednisone—systemic scleroderma	0.000326	0.000913	CcSEcCtD
Rimonabant—Abdominal pain—Methotrexate—systemic scleroderma	0.000325	0.000912	CcSEcCtD
Rimonabant—Vomiting—Prednisone—systemic scleroderma	0.000313	0.000878	CcSEcCtD
Rimonabant—Rash—Prednisone—systemic scleroderma	0.000311	0.000871	CcSEcCtD
Rimonabant—Dermatitis—Prednisone—systemic scleroderma	0.00031	0.00087	CcSEcCtD
Rimonabant—Headache—Prednisone—systemic scleroderma	0.000309	0.000865	CcSEcCtD
Rimonabant—Asthenia—Methotrexate—systemic scleroderma	0.000295	0.000828	CcSEcCtD
Rimonabant—Nausea—Prednisone—systemic scleroderma	0.000293	0.00082	CcSEcCtD
Rimonabant—Pruritus—Methotrexate—systemic scleroderma	0.000291	0.000817	CcSEcCtD
Rimonabant—Diarrhoea—Methotrexate—systemic scleroderma	0.000282	0.00079	CcSEcCtD
Rimonabant—Dizziness—Methotrexate—systemic scleroderma	0.000272	0.000763	CcSEcCtD
Rimonabant—Vomiting—Methotrexate—systemic scleroderma	0.000262	0.000734	CcSEcCtD
Rimonabant—Rash—Methotrexate—systemic scleroderma	0.00026	0.000728	CcSEcCtD
Rimonabant—Dermatitis—Methotrexate—systemic scleroderma	0.000259	0.000727	CcSEcCtD
Rimonabant—Headache—Methotrexate—systemic scleroderma	0.000258	0.000723	CcSEcCtD
Rimonabant—Nausea—Methotrexate—systemic scleroderma	0.000245	0.000686	CcSEcCtD
Rimonabant—CYP1A2—digestive system—systemic scleroderma	0.000118	0.0331	CbGeAlD
Rimonabant—CYP2C9—digestive system—systemic scleroderma	0.000112	0.0314	CbGeAlD
Rimonabant—CYP1A2—lung—systemic scleroderma	9.83e-05	0.0276	CbGeAlD
Rimonabant—CYP3A4—digestive system—systemic scleroderma	8.52e-05	0.0239	CbGeAlD
Rimonabant—CYP2D6—digestive system—systemic scleroderma	8.39e-05	0.0236	CbGeAlD
